Gabapentin Capsule 25 mg (Pregabalin)

Adult dose

This medication should be taken orally in divided doses twice daily, regardless of food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose of 150 mg per day can be increased to 300 mg within 3 to 7 days and, if necessary, can be further increased to a maximum of 600 mg per day at intervals of 7 days. - Central Neuropathic Pain: Starting dose of 150 mg can be administered initially.

Child dose

Safety and efficacy data are insufficient for children under 12 years of age and adolescents aged 12 to 17 years, thus administration is not recommended.

This drug is an antiepileptic medication and carries the risk of suicidal thoughts, suicidal behavior, and mental health problems such as depression during use; thus, both the patient and caregiver should closely monitor for these symptoms. This medication should not be administered to patients with hypersensitivity to the ingredients or those with certain genetic lactase deficiency. Patients with diabetes should be cautious as weight gain while using this drug may require adjustments to their diabetes medication regimen. If symptoms of angioedema occur, such as swelling of the face or mouth, discontinue use immediately and consult healthcare professionals. Elderly patients may experience dizziness, drowsiness, or loss of consciousness, especially during the initial stages of treatment, and may also experience changes in vision such as blurred vision. Discontinuing this medication abruptly may lead to withdrawal symptoms such as insomnia, headache, and anxiety; it should be tapered gradually according to healthcare professional instructions. Patients with a history of substance abuse may have a higher risk of misuse of this medication; thus, it should be administered with caution, monitoring for signs of misuse or dependence. Patients with impaired renal function may require dosage adjustments. Patients with heart disease may exhibit congestive heart failure symptoms while taking this medication, thus warranting careful monitoring. Use with other central nervous system depressants, especially opioid analgesics, may increase the risk of respiratory depression; caution is advised. In early pregnancy, there is a risk of fetal malformations; therefore, women who are pregnant or plan to become pregnant should consult healthcare professionals before use and employ effective birth control methods. During breastfeeding, this drug may pass into breast milk and affect infants, so breastfeeding should be avoided or discussed with a healthcare professional. When engaging in activities requiring alertness such as driving or operating machinery, caution is necessary due to the risk of dizziness or drowsiness from this medication. If serious skin rashes or allergic symptoms occur, discontinue use immediately and notify healthcare professionals. Overdosage may cause confusion, drowsiness, seizures, etc., requiring immediate emergency treatment; blood dialysis may be performed if necessary. Keep out of reach of children and avoid transferring to other containers to prevent quality deterioration or accident risks.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by coughing and fever, jaundice, sudden and very severe headaches, thunderclap headaches, seizures, confusion, vision abnormalities, paralysis, significantly reduced urine output.

Mild side effects

• Dizziness
• drowsiness
• nasopharyngitis
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain storage temperatures between 15 to 30 degrees Celsius.

Appearance

Opaque capsule with upper part yellowish and lower part white, containing white or grayish-white powder.

Package unit

30 capsules/bottle, 100 capsules/bottle